Shattuck Labs, Inc. (STTK)
NASDAQ: STTK · Real-Time Price · USD
1.370
+0.080 (6.20%)
At close: Feb 21, 2025, 4:00 PM
1.390
+0.020 (1.46%)
After-hours: Feb 21, 2025, 7:34 PM EST
Shattuck Labs Revenue
Shattuck Labs had revenue of $3.00M in the quarter ending September 30, 2024, with 336.88% growth. This brings the company's revenue in the last twelve months to $6.44M, up 382.75% year-over-year. In the year 2023, Shattuck Labs had annual revenue of $1.66M with 154.14% growth.
Revenue (ttm)
$6.44M
Revenue Growth
+382.75%
P/S Ratio
10.39
Revenue / Employee
$85,800
Employees
75
Market Cap
65.40M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
STTK News
- 2 days ago - Shattuck Labs Announces Positive Data from the Preclinical GLP Toxicology Study of SL-325 at the 20th Congress of European Crohn's and Colitis Organization (ECCO) in Inflammatory Bowel Diseases 2025 - GlobeNewsWire
- 9 days ago - Shattuck Labs Announces Oral Presentation at Upcoming 20th Congress of European Crohn's and Colitis Organization (ECCO) in Inflammatory Bowel Diseases 2025 - GlobeNewsWire
- 18 days ago - Shattuck Labs Announces Poster Presentation at Upcoming 2025 Crohn's and Colitis Congress - GlobeNewsWire
- 6 weeks ago - Shattuck Labs Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2025 - GlobeNewsWire
- 4 months ago - Shattuck Labs, Inc. (STTK) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Accesswire
- 4 months ago - Bronstein, Gewirtz & Grossman, LLC Encourages Shattuck Labs, Inc. (STTK) Shareholders to Inquire about Securities Investigation - Accesswire
- 4 months ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Shattuck Labs, Inc. (STTK) And Encourages Shareholders to Connect - Accesswire